In a Monday letter, a group of 350 organizations urged Congress to make Covid-19 Medicare telehealth flexibilities permanent. If Congress can’t make these flexibilities —which are set to expire in ...

Pfizer claims Metsera breached their merger agreement, adding that a tie-up of the biotech with GLP-1 drug giant Novo Nordisk ...

Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked epidemics plaguing healthcare: prescription drug abuse. Before Covid-19 ...

Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...

With $50 billion set to flow to states over the next five years, CMS’ new Rural Health Transformation Program represents one of the largest federal investments in rural healthcare in decades. However, ...

With federal PBM reform stalled, states like California are stepping up with laws like SB 41 to boost transparency and lower drug costs.

Digital health funding has remained steady this year, with AI startups increasingly capturing a larger share of venture capital. In the first half of this year, AI-focused startups captured a majority ...

Is Risant Health the rising star of scalable, profitable value-based care models for health systems? It’s a little early to break out the champagne and toast to the company’s success, but it might ...

The expiration of ACA tax credits could drive up premiums across marketplace and commercial insurance plans, a Cigna executive warned.

The use of AI in healthcare has evolved quite a bit over the past few years — with many healthcare organizations transitioning from a state of cautious experimentation to more serious attempts at ...

Advanced prostate cancer has a new treatment option, a Johnson & Johnson drug that combines two of the company’s therapies in a single pill. Niraparib is small molecule designed to block PARP, an ...